Literature DB >> 10809338

HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10809338

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  5 in total

1.  Therapeutic ranges of serum digoxin concentrations in patients with heart failure.

Authors:  Zachary D Goldberger; Ary L Goldberger
Journal:  Am J Cardiol       Date:  2012-04-11       Impact factor: 2.778

2.  Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.

Authors:  Tatyana Weitsman; Giora Weisz; Andre Keren; Tal Hasin
Journal:  Clin Res Cardiol       Date:  2016-04-18       Impact factor: 5.460

3.  New developments in the surgical management of end-stage heart failure.

Authors:  Scott Silvestry
Journal:  Mo Med       Date:  2012 Jul-Aug

4.  Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure.

Authors:  Weiming Li; Rong Rong; Sheng Zhao; Xiaoming Zhu; Ke Zhang; Xin Xiong; Xueqing Yu; Qinghua Cui; Shuqiang Li; Li Chen; Jun Cai; Jie Du
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

Review 5.  Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist.

Authors:  Paolo Severino; Paul J Mather; Mariateresa Pucci; Andrea D'Amato; Marco Valerio Mariani; Fabio Infusino; Lucia Ilaria Birtolo; Viviana Maestrini; Massimo Mancone; Francesco Fedele
Journal:  Diagnostics (Basel)       Date:  2019-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.